Modulation of endogenous IL-1βand IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3501-3508

  Goletti, Delia ^a   Kinter, Audrey L ^a   Hardy, Elena C ^a   Poli, Guido ^b   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS EXPRESSION;

ANTIVIRAL AGENTS; BASE SEQUENCE; BINDING SITES; CELL LINE; CYTOKINES; DRUG SYNERGISM; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HIV; HIV LONG TERMINAL REPEAT; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; MONOCYTES; NF-KAPPA B; RNA, VIRAL; SIALOGLYCOPROTEINS; VIRUS ACTIVATION;

EID: 0030012749     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011.
2. Poli, G., A. L. Kinter, J. S. Justement, P. Biswas, D. Weissman, L. M. Fox, D. Goletti, P. Bressler, S. K. Stanley, and A. S. Fauci. 1993. The chronically infected promonocytic cell line U1: a model of HIV expression regulated by cytokines. ImmunoMethods 3:50.
3. Koyanagi, Y., W. A. O'Brien, J. Q. Zhao, D. W. Golde, J. C. Gasson, and I. S. Y. Chen. 1988. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 241:1673.
4. Goletti, D., A. L. Kinter, P. Biswas, S. M. Bende, G. Poli, and A. S. Fauci. 1995. Effect of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and viral expression. J. Virol. 69:2540.
5. Poli, G., P. Bressler, A. L. Kinter, E. Duh, W. C. Timmer, A. Rabson, J. S. Justement, S. K. Stanley, and A. S. Fauci. 1990. Interleukin 6 induces human immunodeficiency virus in infected monocytic cells alone and in synergy with rumor necrosis factor-alpha by transcriptional and post-transcriptional mechanisms. J. Exp. Med. 172:151.
6. + model of chronic infection. J. Immunol. 150:625.
7. Weissman, D., G. Poli, and A. S. Fauci. 1994. Interleukin-10 blocks HIV replication in macrophages by inhibiting the autocrine loop of TNF-α and IL-6 induction of virus. AIDS Res. Hum. Retroviruses 10:1199.
8. Kinter, A. L., G. Poli, L. Fox, E. Hardy, and A. S. Fauci. 1995. HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/ paracrine manner by endogenous cytokines. J. Immunol. 154:2448.
9. Vyakamam, A., J. McKeating, A. Meager, and P. C. Beverly. 1990. Tumor necrosis factors (α,β) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 4:21.
10. Yamamoto, J. K., F. Barre-Sinoussi, V. Bolton, N. C. Pedersen, and M. B. Gardner. 1986. Human alpha- and beta-interferon but not gamma- suppresses the in vitro replication of LAV. HTLV-III, and ARV-2. J. Interferon Res. 6:143.
11. Hartshorn, K. L., D. Neumeyer, M. W. Vogt, R. T. Schooley, and M. S. Hirsch. 1987. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. AIDS Res. Hum. Retroviruses 3:125.
12. Poli, G., A. L. Kinter, J. S. Justement, P. Bressler, J. H. Kehrl, and A. S. Fauci. 1991. Transforming growth factor β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J. Exp. Med. 173:589.
13. Schuitemaker, H., N. A. Kootstra, M. H. G. M. Koppelman, S. M. Bruisten, H. G. Huisman, M. Tersmette, and F. Miedema. 1992. Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages. J. Clin. Invest. 89:1154.
14. Montaner, L. J., A. G. Doyle, M. Collin, G. Herbein, P. Illei, W. James, A. Minty, D. Caput, P. Ferrara, and S. Gordon. 1993. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J. Exp. Med. 178:743.
15. Bauer J., U. Ganter, T. Geiger, U. Jacobshagen, T. Hirano, T. Matsuda, T. Kishimoto, T. Andus, G. Acs, W. Gerok, and G. Ciliberto. 1988. Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood 72:1134.
16. Burchett S. K., W. M. Weaver, J. A. Westall, A. Larsen, S. Kronheim, and C. B. Wilson. 1988. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J. Immunol. 1140:3473.
17. Drouet C., A. N. Shakhov, and C. V. Jongeneel. 1991. Enhancers and transcription factors controlling the inducibility of the TNF-α promoter in primary macrophages. J. Immunol. 147:1694.
18. Damas, P., A. Reuter, P. Gysen, J. Demonty, M. Lamy, and P. Franchimont. 1989. Tumor necrosis factor and interleukin-1 serum levels during sepsis in humans. Crit. Care Med. 17:975.
19. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey, A. Zentella, J. D. Albert, T. Shires, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470.
20. Friedland, J. S., Y. Suputtamongkol, D. G. Remick, W. Chaowagul, R. M. Stricter, S. L. Kunkel, N. J. White, and G. E. Griffin. 1992. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect. Immun. 60:2402.
21. Gómez-Jiménez, J., M. C. Martín, R. Sauri, R. M. Segura, F. Esteban, J. C. Ruiz, X. Nuvials, J. L. Bóveda, R. Peracaula, and A. Salgado. 1995. Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock. J. Infect. Dis. 171:472.
22. Hufert, F. T., J. Schmitz, M. Schreiber, H. Schmitz, P. Rácz, and D. D. von Laer. 1993. Human Kupffer cells infected with HIV-1 in vivo. J. Acquir. Immune Defic. Syndr. 6:772.
23. Smith, P. D., T. C. Quinn, W. Strober, E. N. Janoff, and H. Masur. 1992. Gastrointestinal infections in AIDS. Ann. Intern. Med. 116:63.
24. Fish, D. N., and L. H. Danziger. 1993. Neglected pathogens: bacterial infections in persons with human immunodeficiency virus infection: a review of the literature. Pharmacotherapy 13:415.
25. Pomerantz, R. J., M. B. Feinberg, D. Trono, and D. Baltimore. 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172:253.
26. Bagasra, O., S. D. Wright, T. Seshamma, J. W. Oakes, and R. J. Pomerantz. 1992. CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide. Proc. Natl. Acad. Sci. USA 89: 6285.
27. Kornbluth, R. S., P. S. Oh, J. R. Munis, P. H. Cleveland, and D. D. Richman. 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169: 1137.
28. Shattock, R. J., J. S. Friedland, and G. E. Griffin. 1993. Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation. J. Virol. 67:3569.
29. von Briesen, H., C. von Mallinckrodt, R. Esser, S. Müller, K. Decker, H. Rübsamen-Waigmann, and R. Andreesen, R. 1991. Effect of cytokines and lipopolysaccharide on HIV infection of human macrophages. Res. Virol. 142:197.
30. Peterson, P. K., G. Gekker, S. Hu, Y. Schoolov, H. H. Balfour, Jr., and C. C. Chao. 1992. Microglial cell upregulation of HIV-1 expression in the chronically infected promonocylic cell line U1: the role of tumor necrosis factor-α. J. Neuroimmunol 41:81.
31. Bressler, P., G. Pantaleo, A. Demaria, and A. S. Fauci. 1991. Anti-CD2 receptor antibodies activate the long terminal repeat in T lymphocytes. J. Immunol. 147: 2290.
32. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
33. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts,' prepared from a small number of cells. Nucleic Acids Res. 17:6419.
34. Weissman, D., G. Poli, and A. S. Fauci. 1995. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9:442.
35. Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharide. Immunochemistry 13:813.
36. Latham, P. S., A. M. Lewis, L. Varesio, G. N. Plavakis, B. K. Felber, F. W. Ruscetti, and H. A. Young. 1990. Expression of human immunodeficiency virus long terminal repeat in the human promonocyte cell line U937: effect of endotoxin and cytokines. Cell. Immunol. 129:513.
37. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor-alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor KB. Proc. Natl Acad. Sci. USA 86:2336.
38. Cordle S. R., R. Donald, M. A. Read, J. Hawiger. 1993. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells. J. Biol. Chem. 268:11603.
39. Poli, G., A. L. Kinter, J. S. Justement, J. H. Kehrl, P. Bressler, S. K. Stanley, and A. S. Fauci. 1990. Tumor necrosis factor-α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA 87:782.
40. Dinarello, C. A. 1994. Blocking interleukin-1 receptors. Int. J. Clin. Lab. Res. 24:61.
41. Turner, M., D. Chantry, P. Katsikis, A. Berger, F. M. Brennan, and M. Feldmann. 1991. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-ß. Eur. J. Immunol. 21:1635.
42. de Waal Malefyl, R., J. Abrams, B. Bennett, C. Figdor, and J. de Vries. 1991. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
43. de Waal Malefyt, R., C. G. Figdor, R. Huijbens, S. Mohan-Peterson, B. Bennett, J. Culpepper, W. Dang, G. Zurawski, and J. E. de Vries. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. J. Immunol. 151:6370.
44. Wong, H. L., G. L. Costa, M. T. Lotze, and S. M. Wahl. 1993. Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo. J. Exp. Med. 177:775.
45. Moldawer, L. L. 1994. Biology of proinflammatory cytokines and their antagonists. Crit. Care Med. 22:53.
46. Granowitz, E. V., B. D. Clark, E. Vannier, M. V. Callahan, and C. A. Dinarello. 1992. Effect of interleukin-1 (UL-1) blockade on cytokine synthesis. I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes. Blood. 9:2356.
47. Granowitz, E. V., E. Vannier, D. D. Poutsiaka, and C. A. Dinarello. 1992. Effect of interleukin-1 (IL-1) blockade on cytokine synthesis. IL IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes. Blood. 9:2356.
48. Wright, S. D. 1995. CD14 and innate recognition of bacteria. J. Immunol. 155:6.
49. Poli, G., A. L. Kinter, and A. S. Fauci. 1994. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA 91:108.
50. Gallo, P., K. Frei, C. Rordorf, J. Lazdins, B. Tavolato, and A. Fontana. 1989. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J. Neuroimmunol. 23: 109.
51. Emilie, D., M. Peuchmaur, M. C. Maillot, M. C. Crevon, N. Brousse, J. F. Delfraissy. J. Dormont, and P. Galanaud. 1990. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J. Clin. Invest. 86:148.
52. Dreno, B., B. Milpied, H. Dutartre, and P. Litoux. 1990. Epidermal interleukin 1 in normal skin of patients with HIV infection. Br. J. Dermatol 123:487.
53. Steffen, M., H. C. Reinecker, J. Petersen, C. Doehn, I. Pfluger, A. Voss, and A. Raedler. 1993. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes and alveolar macrophages from HIV-infected patients. Clin. Exp. Immunol. 91:30.
54. Lathey, J. L., S. Kanangat, B. T. Rouse, J. M. Agosti, and S. A. Spector. 1994. Dysregulation of cytokine expression in monocytes from HIV-positive individuals. J. Leukocyte. Biol. 56:347.
55. Peters, A. M. J., F.-S. Jäger. A. Warneke, K. Müller, U. Brunkhorst, I. Schedel, and M. Gahr. 1991. Cytokine secretion by peripheral blood monocytes from human immunodeficiency virus-infected patients is normal. Clin. Immunol. Immunopathol. 61:343.
56. Gershenwald, J. E., Y. M. Fong, T. J. Fahey, S. E. Calvano, R. Chizzonite, P. L. Kilian, S. F. Lowry, and L. L. Moldawer. 1990. Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc. Natl Acad. Sci. USA 87:4966.
57. Porat, R., D. D. Poutsiaka, L. C. Miller, E. V. Granowitz, and C. A. Dinarello. 1992. Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells. FASEB J. 6:2482.